Premier Alternatives

Holmusk

New York, NY · Founded 2015 · Privately Held (backing)

Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical understanding. Holmusk is based in New York, NY and was founded in 2015. Its last reported valuation was $135 million in Jan 2023. It has raised $114 million across 1 recorded round; the latest was a $30 million early-stage round in Sep 2023.

Last reported valuation
$134.8M
Oct 2026
Priced at
—
Total raised
$113.8M
Last round
Early Stage VC
Sep 2023

Holmusk key facts

as of Oct 2026
  • Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical understanding.
  • Holmusk is valued at approximately $134.8M as of Oct 2026 (last reported valuation).
  • It has raised $113.8M across 1 recorded rounds; the latest was Early Stage VC ($30.0M) in Sep 2023.
  • Notable investors include Johnson & Johnson JJDC, Optum Ventures, OCTAVE Capital (Singapore), Capikris Foundation, Health Catalyst Capital Management — 14 tracked in total.
  • Holmusk has filed 1 Form D with the SEC, most recently Oct 2023 ($30.0M sold to 1 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$134.8M

Holmusk's last reported valuation, Jan 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Holmusk with a free account
  • ·The complete investor list: 14 names
  • ·Watch Holmusk: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Holmusk funding rounds

1 rounds
Sep 2023Early Stage VC$30.0MSEC filing▮
Full funding history →

Holmusk valuation

Holmusk's last reported valuation was $135 million in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Holmusk raised?

Holmusk has raised $114 million in total; 1 of its rounds is on record. The largest on record was a $30 million early-stage round in Sep 2023.

Holmusk has filed 1 Form D with the SEC, most recently in Oct 2023 ($30 million sold to 1 investor).

Holmusk investors

14 investors are on record for Holmusk, including Johnson & Johnson JJDC, Optum Ventures, OCTAVE Capital (Singapore) and Capikris Foundation. The early-stage round in Sep 2023 drew 1 investor.

About Holmusk

Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical understanding. The company's platform incorporates a longitudinal de-identified database and more than one million patients, combines natural language processing, predictive disease models, and analytics dashboards, enabling researchers, healthcare providers, and payers to derive evidence-based insights for treatment development, care delivery optimization, and regulatory decision-making.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2015
Employees
101
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.